We are pleased to recognize the following funding partners:
Innovation, Science and Economic Development Canada (ISED) works with Canadians in all areas of the economy and in all parts of the country to improve conditions for investment, enhance Canada's innovation performance, increase Canada's share of global trade and build a fair, efficient and competitive marketplace. For more information visit: www.ic.gc.ca/eic/site/icgc.nsf/eng/home
The Ministère de l’Économie et de l’Innovation (MEI) has the mission to support business growth, entrepreneurship, science, innovation, export trade and investment. The MEI is coordinating the elaboration and the implementation of the digital strategy.
It also advises the Government with a view to favouring economic development in every region of Québec, in a perspective of: job creation, economic prosperity, and sustainable development. For more information, please visit their website: www.quebec.ca/en/
COMMERCIAL INNOVATION COMPLEXES (CIC) :
On December 7th, 2018, the City of Montreal granted financial support to the NEOMED Institute for the implementation of the first CIC in life sciences and health technologies (LSHT). As part of its new 2018-2022 Economic Development Strategy Accélérer Montréal, the City of Montreal plans to set up CICs on its territory in order to improve the ecosystem of business sectors related to the orientations of its strategy.
CIC’s primary mission will be to facilitate the development and integration of innovative technologies, processes and approaches at all levels of the organization and at all stages of the corporate lifecycle, most notably at the growth stage. One of the objectives is to increase the productivity of companies so that they become more efficient and more competitive in the global market.
Among the targeted sectors of activity, in addition to LSHT, there are industry 4.0, bio-food, transportation and mobility related to artificial intelligence, and clean technologies. For more information, please visit: http://ville.montreal.qc.ca/affaires
Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., the world’s leading biopharmaceutical company. Pfizer discovers, develops, manufactures and markets prescription medicines for humans and animals. Pfizer Inc. invests more than US $7 billion annually in R&D to discover and develop innovative life-saving and life-enhancing medicines in a wide range of therapeutic areas.
Their diversified healthcare portfolio includes human and animal biologic and small-molecule medicines and vaccines, and many of the world’s best-known consumer products. For more information, please visit their website: www.pfizer.ca
Founded in Montreal in 1892, ROBIC is internationally renowned and has earned a reputation for excellence in intellectual property in Canada.
Nationally, ROBIC is ranked fifth largest trademark agent by volume of applications filed and has earned an undeniable reputation for the quality and number of patents filed annually in Canada. Their experienced litigation lawyers, some of whom are recognized by their peers as being the best intellectual property litigators in the country, represent their clients in all courts, including the Federal Court of Canada, provincial courts in Quebec, the Supreme Court of Canada, as well as specialized administrative tribunals.
In addition to offering all intellectual property services, ROBIC has an experienced team of business lawyers whose expertise is recognized internationally. Their business law team advises has earned an enviable reputation in areas such as corporate and commercial law, and other more specialized areas of business law, including technology transfer and licensing, competition, telecommunications and information technology.
For 125 years, ROBIC has been the benchmark for the protection and commercialization of intellectual property rights and other intangible assets in Canada. For more information visit: www.robic.ca/en/home